Software as a Medical Device (SaMD) Registration in the European Union (EU) Market
SaMD Registration in the EU: Bringing Software as a Medical Device (SaMD) to the European Union requires compliance with the EU Medical Device Regulation (MDR) 2017/745 and the In Vitro Diagnostic Regulation (IVDR) 2017/746. Masuu Global Solutions supports manufacturers through every phase of compliance, CE marking, and market entry, ensuring that your digital health innovation meets EU expectations for safety, performance, and reliability.
Overview
The European SaMD landscape is expanding rapidly due to increased adoption of remote health technologies, AI-driven diagnostics, and software based clinical tools. In the EU, the term “Software as a Medical Device (SaMD)” is not used formally—instead, such products are regulated as Medical Device Software (MDSW) under MDR and IVDR.
These regulations establish strict criteria for software design, development, validation, cybersecurity, clinical evidence, and post market obligations.
Performance Evaluation – Market Context
The global surge in digital health has accelerated demand for independent medical software, including decision support tools, diagnostic applications, and virtual monitoring platforms. The EU market continues to grow as healthcare shifts toward interoperable systems and data driven care delivery.
MDR/IVDR ensures that such software meets rigorous safety, performance, and clinical evidence requirements before it reaches patients or clinicians.
How Does Software Qualify as a Medical Device in the EU?
- It is intended to perform one or more medical functions, such as diagnosis, monitoring, prediction, or treatment.
- It executes these functions independently of hardware.
- It controls, drives, or influences a hardware medical device (this is classified as SiMD — Software in a Medical Device).
- Its functions are not related to medical purposes as defined by MDR/IVDR.
Masuu Global Solutions helps you determine qualification, classification, and the correct regulatory pathway.
How to Register Your SaMD in the EU (MDR/IVDR Pathway)
Determine Qualification and Classification
- Classification follows MDR rules (particularly Rule 11), based on the risk to patients and users.
- Higher risk software classes typically require involvement of a Notified Body (NB).
Conduct a Conformity Assessment
- Review of Quality Management System (QMS) under ISO 13485
- Examination of software lifecycle documentation (IEC 62304)
- Cybersecurity (IEC 81001 5 1 / MDCG guidance)
- Clinical evaluation requirements
- Risk management (ISO 14971)
Prepare Technical Documentation
- Software design and architecture
- Verification and validation reports
- Clinical evidence
- Usability engineering
- Cybersecurity controls
- Post market surveillance plans
Achieve CE Marking
Once the Notified Body approves the conformity assessment (for applicable classes), the manufacturer may affix the CE mark.
Register in EUDAMED
Manufacturers, authorized representatives, and the device itself must be registered in the European Database on Medical Devices.
Maintain Post Market Requirements
Post market surveillance, vigilance, PMS reporting, and periodic updates are mandatory to maintain EU compliance.
Masuu Global Solutions provides full lifecycle support—including documentation, CE marking preparation, NB coordination, and PMS guidance.
Masuu Global Solutions – SaMD Registration Support for Europe, Australia & Korea
Expertise
- Tailored MDR/IVDR regulatory strategy for SaMD
- In depth market and regulatory intelligence
- SaMD classification and registration services
- Support throughout product development documentation
- Guidance for clinical evaluation and performance studies
- Post approval lifecycle management
- EU / UK / Switzerland authorized representative services
Advantages
- Proven success supporting SaMD approvals across various classes
- Skilled regulatory experts dedicated to MDR/IVDR compliance
- Timely and predictable submission processes
- Local partners to address HA requirements and language needs
- Cost effective in country representation options
- Flexible regulatory staffing and resource augmentation
Frequently Asked Questions
EU medical software is regulated as Medical Device Software (MDSW) under the MDR or IVDR, depending on its intended medical purpose. Registration involves determining qualification and classification, preparing technical documentation, completing the applicable conformity assessment, obtaining CE marking where required, registering relevant entities and devices in EUDAMED, and meeting post-market obligations.
Software may qualify as a medical device under EU MDR when it has an intended medical purpose such as diagnosis, monitoring, prediction, or treatment and performs its function independently of dedicated medical hardware. Software that controls or influences a hardware medical device may instead be considered Software in a Medical Device (SiMD).
EU MDR Rule 11 classifies software according to the information it provides and the potential impact of its decisions on patients or users. Software providing information used for diagnostic or therapeutic decisions can fall into higher-risk classes depending on the circumstances. The classification determines the applicable conformity assessment requirements.
Notified Body involvement depends on the MDSW classification and applicable conformity assessment route. Higher-risk software generally requires Notified Body assessment, while certain lower-risk devices may follow a conformity route without Notified Body involvement. The manufacturer must determine the correct classification before selecting the conformity assessment procedure.
EU MDSW technical documentation can include software design and architecture information, verification and validation evidence, clinical evaluation, risk management documentation, usability engineering, cybersecurity controls, and post-market surveillance plans. The documentation should demonstrate that the software meets applicable MDR safety and performance requirements and supports the selected conformity assessment pathway.
EU MDSW development and compliance may involve IEC 62304 for software lifecycle processes, ISO 14971 for medical device risk management, ISO 13485 for quality management, and applicable cybersecurity standards such as IEC 81001-5-1. MDCG guidance should also be considered when interpreting EU requirements for medical device software.
Clinical evaluation should demonstrate that the software meets applicable safety and performance requirements and supports its intended medical purpose. The evidence strategy depends on the software’s classification, intended use, clinical claims, and risk profile. Technical documentation should include appropriate clinical evidence as part of the conformity assessment process.
CE marking requires the manufacturer to demonstrate conformity with applicable EU MDR or IVDR requirements through the appropriate conformity assessment procedure. Depending on the software classification, this may involve a Notified Body, quality management system assessment, technical documentation review, clinical evaluation, risk management, and software validation before the CE mark is affixed.
EUDAMED is the European Database on Medical Devices and forms part of the EU medical device regulatory framework. Manufacturers, authorized representatives, and devices are subject to applicable registration requirements. The manufacturer should ensure that required entity and device information is entered and maintained according to the applicable EU requirements.
CE marking does not end the manufacturer’s regulatory responsibilities. EU medical device software must be supported by ongoing post-market surveillance, vigilance activities, applicable PMS reporting, and lifecycle updates. Manufacturers should continue monitoring software performance and safety information and maintain documentation to demonstrate continued compliance with MDR or IVDR requirements.
